A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer. Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic ...
Read MoreSAN ?WANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) -- Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza ® pre-filled pen, ...
Read MoreTAIPEI, Taiwan, June 12, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, a clinical-stage oncology company (4174.TWO), today announced the initiation of a Phase 1/2 clinical trial of OBI-992, an antibody-drug conjugate (ADC) targeting TROP2 (Trophoblast ...
Read MoreHOLON, Israel , June 17, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that Pierre Ferré, Ph.D, SVP, ...
Read MoreNANJING , China , June 17, 2024 /PRNewswire/ -- At the recent European League Against Rheumatism (EULAR) Congress in Vienna, Austria , Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) delivered an oral presentation on its highly innovative ...
Read MoreSHANGHAI and NANJING , China and SAN JOSE, Calif. , June 15, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies ...
Read MoreGATINEAU , QC , June 15, 2024 /CNW/ - The Minister of Labour and Seniors, Seamus O'Regan Jr. , and the Minister of Mental Health and Addictions and Associate Minister of Health, Ya'ara Saks, issued the following statement on World Elder ...
Read MoreRVU120 as a single agent showed clinical benefit in heavily pretreated patients with AML and HR-MDS in the Phase 1 RIVER-51 study (CLI120-001). The strongest evidence of benefit was observed in patients with NPM1 and/or DNMT3A mutations and in ...
Read MoreAt-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data AUSTIN, Texas , June 14, 2024 /PRNewswire/ -- Mindbloom , the leading ...
Read More- Data continue to support revumenib's potential to enhance current standard of care agents - - 96% CRc (23 of 24 pts) observed in BEAT AML trial exploring revumenib in combination with venetoclax/azacitidine in newly diagnosed mNPM1 or KMT2Ar ...
Read MoreA single intra-articular injection of 3mL of MM-II provided greater pain relief than placebo for up to 26 weeks From weeks 12 to 26, more patients on MM-II experienced a =50% improvement in knee OA pain than patients on placebo and used ...
Read MoreWhiteFlag announces an exciting partnership with RPM Productions to champion mental health awareness and support among Miss USA contestants, leveraging their platform to destigmatize mental health issues and promote anonymous peer support. This ...
Read MoreTemporary vessel occlusion a growing practice for trauma patients. SALT LAKE CITY , June 13, 2024 /PRNewswire/ -- Emergency Scientific, a Utah -based medical device company specializing in innovative solutions for the emergency medicine ...
Read More– LG Chem to embark on developing Next-Generation Immune Checkpoint Inhibitors to Provide Solid Tumor Treatment Solutions – – LG Chem and AVEO Oncology continuing to advance its shared vision of becoming a leading global oncology company – ...
Read MoreThrough the Johns Hopkins Kimmel Cancer Center's M.A.P.S. (Mentorship and Peer Support) program, an adult cancer patient and/or caregiver can be matched with a trained peer mentor who has been through a similar experience. CHESTER, N.J. and ...
Read MorePharmacokinetic data from the CHERISH study suggest that pregnant women treated with certolizumab pegol can maintain their dosing regimen throughout pregnancy An in vitro study found that rheumatoid factor (RF) antibodies bind to Fc-containing ...
Read MoreHONG KONG , GERMANTOWN, Md. and SUZHOU, China , June 13, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company"; together with its subsidiaries, " Sirnaomics " or the " Group "; stock code: 2257), a leading biopharmaceutical company in ...
Read MoreaXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, permanent, living vessel EINDHOVEN, The Netherlands , June 13, 2024 /PRNewswire/ -- Xeltis, a leading ...
Read MoreNEUCHÂTEL, Switzerland , June 12, 2024 /PRNewswire/ -- Aktiia, the Swiss startup revolutionizing Blood Pressure (BP) monitoring and management, announces it has received regulatory approval (CE mark) for its next-generation optical ...
Read MoreUSA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC , June 12, 2024 /PRNewswire/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers ...
Read MoreThe National Institute on Deafness and Other Communication Disorders (NIDCD) , a member of the U.S. NIH to provide Remmie Health with nearly $3 million in support, subject to the availability of funds SEATTLE , June 12, 2024 ...
Read MoreMedical imaging AI company receives approval for algorithm enabling opportunistic detection and triage of vertebral compression fractures. La Ciotat, FRANCE , June 12, 2024 /PRNewswire/ -- Avicenna.AI , a leading medical imaging AI ...
Read MoreFranchised provider of in-home caregiving services enhances DementiaWise program to address growing need of person-centered care TROY, Mich. , June 12, 2024 /PRNewswire/ -- ComForCare , a franchised provider of in-home caregiving ...
Read MoreLeading Pediatric Osteosarcoma Nonprofit to Present $350,000 to 5 Scientists on June 21 to Find Kinder Treatments for Patients BARNARD, Vt . , June 12, 2024 /PRNewswire/ -- MIB Agents , a leading pediatric osteosarcoma nonprofit ...
Read MoreINDIANAPOLIS , June 12, 2024 /PRNewswire/ -- Prevounce Health , a leading provider of remote care management software, devices, and services, announces the launch of its first remote blood glucose monitoring device: Pylo GL1-LTE. The ...
Read MorePatients with non-radiographic axial spondyloarthritis (nr-axSpA) and those with ankylosing spondylitis (AS) treated with BIMZELX showed sustained and consistent clinical and patient-reported outcomes up to two years Late-breaking data revealed ...
Read MoreSAN FRANCISCO and SUZHOU, China , June 11, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Read MoreCOPENHAGEN , Denmark , June 11, 2024 /PRNewswire/ -- In an era where climate change poses a critical threat to biodiversity and agricultural productivity, a pioneering research project that harnesses environmental DNA ('eDNA'), sets out to ...
Read MoreThe initiative seeks to decrease the number of non-traumatic lower extremity amputations as a result of Peripheral Artery Disease with early detection screenings. MIAMI , June 11, 2024 /PRNewswire/ -- The Amavita Foundation, the ...
Read MoreA new chapter in the history of nuclear energy storage solutions could be written by this new, highly efficient, scalable, and mass-producible nuclear battery technology. SAN DIEGO , June 11, 2024 /PRNewswire/ -- Infinity Power in San ...
Read MoreCluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials KING OF PRUSSIA, Pa. , June 11, 2024 /PRNewswire/ -- CluePoints , provider of leading statistical and AI-driven software solutions, today ...
Read MoreAvenda Health's study, published in The Journal of Urology, solidifies the power of AI in oncology as a viable and accurate diagnostic tool CULVER CITY, Calif. , June 11, 2024 /PRNewswire/ -- Avenda Health , an AI healthcare company ...
Read MoreNOYCIA recognizes excellence in Canadian oncology research as part of Novartis Canada's commitment to reimagining medicine MONTREAL , June 11, 2024 /CNW/ - Novartis Canada is pleased to announce the winners of the 2024 Novartis ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers